All In Biotech

Drug Trial Radar · NCT02176876

Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

A Phase 1b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

Last checked: Nov 20, 2026Latest source record: Jun 29, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

18

Actual

Start

Aug 2014

Primary completion

Apr 2015

Study completion Jun 2015

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Jun 27, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to assess the safety, tolerability, and pharmacokinetics (PK) of multiple infusions of GS-5745 in adults with rheumatoid arthritis (RA). Participants will be randomized in a 4:1 ratio to receive 1 intravenous (IV) infusion of GS-5745 or placebo every 2 weeks, for a total of 3 IV infusions.

Conditions

  • Rheumatoid Arthritis

Interventions

  • GS-5745Drug

    GS-5745 400 mg administered intravenously

  • Placebo to match GS-5745Drug

    Placebo to match GS-5745 administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events, changes in laboratory tests and vital signs from baseline, and development of immunogenicity after dosingTime frame: Up to 100 days

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Site not named

    Prague, Czechia

  • Site not named

    Budapest, Hungary

  • Site not named

    Debrecen, Hungary

  • Site not named

    Balatonfüred, Veszprém megye, Hungary

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.